The report is available in English with a French summary - KCE

More documents

Recommendations

Info

KCE reports 57 Musculoskeletal & Neurological Rehabilitation 228 Figure 10.7: Costs to the rehabilitation centre of the different rehabilitation protocols for 5 selected pathologies (Euro) According to expert protocol Calculated staff costs Allocated overhead costs according to duration of rehabilitation activity (2 scenarios: € 15/hour and € 25/hour) Calculated total costs (staff + overhead) Days (hosp) or sessions Cost Hours Allocated Cost medical paramedical Total staff rehabilitation overhead Allocated overhead Total cost (if overhead Total cost (if overhead (amb) Weeks staff staff costs activities (€ 15/hour) (€ 25/hour) is € 15/hour) is € 25/hour THR polypathology 25 3.57 198 718 916 23 342 569 1 258 1 485 THR fragile 7 1.00 56 201 257 6 96 159 352 416 LEA BK 28 4.00 444 1 630 2 075 50 750 1 250 2 825 3 325 LEA AK, Hospitalization 70 10.00 1 111 5 095 6 206 153 2 288 3 813 8 494 10 019 LEA AK, ambulatory 20 10.00 370 1 853 2 223 55 825 1 375 3 048 3.598 SCI (paraplegia), Hosp. 175 25.00 3 702 16 166 19 868 497 7 453 12 422 27 321 32 290 SCI (paraplegia), amb 60 20.00 740 2 713 3 454 85 1 275 2 125 4 729 5 579 SCI (tetraplegia), Hosp 273 39.00 5 776 24 911 30 687 775 11 627 19 378 42 313 50 065 SCI (tetraplegia), amb 78 26.00 1 203 3 484 4 687 114 1 706 2 844 6 394 7 531 MS, Hospitalization 28 4.00 592 2 555 3 147 80 1 193 1 988 4 340 5 135 MS ambulatory 104 52.00 1 925 4 646 6 571 156 2 340 3 900 8 911 10 471 Stroke, Hospitalization 112 16.00 2 370 7 075 9 445 230 3 450 5 750 12 895 15 195 Stroke, ambulatory 120 60.00 2 221 5 360 7 581 180 2 700 4 500 10 281 12 081
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 229 10.3.2 Revenues and RIZIV expenses for the rehabilitation protocols under current reimbursement rules The results of the calculations of the centre revenues and RIZIV/INAMI expenses corresponding to each rehabilitation protocol are presented in Figure 10.8: . The table shows the revenues per treatment protocol and the RIZIV/INAMI expenditures according to the current reimbursement mechanisms. As most rehabilitation programmes can be financed through different mechanisms three scenarios are presented, In addition, the theoretical future revenues for THR under the not yet implemented K30/K45/K60 system were calculated (results not in table but described in text). The royal decree for the implementation of the K45-nomenclature is waiting for publication. A K45 is worth €46.62 and represents a session of 90 minutes. (Note that, according to the described protocols, only 15% of all THR deserve multidisciplinary rehabilitation (THR combined with polypathology or in fragile patients)). For comparative purposes, the total costs borne by the rehabilitation centres for each rehabilitation protocol, assuming an overhead cost of €15/hour, are presented in Figure 10.8: . This comparison shows that for all rehabilitation paths in all reimbursement systems, except for ambulatory rehabilitation for MS, the theoretical costs are higher than the revenues. For the ambulatory rehabilitation protocol for MS, revenues under convention 7.71 are higher than theoretical costs. Under the future K30/K45/K60 system, the revenues for the treatment of THR polypathology becomes €839.16 and for the treatment of THR fragile €233.10.
Page 1 and 2:
Organisation et Financement de la R
Page 3 and 4:
Organisation et financement de la r
Page 5 and 6:
KCE Reports 57B Réadaptation locom
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
KCE Reports 57 Musculoskeletal & Ne
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
KCE reports 57 Musculoskeletal & Ne
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192: KCE reports 57 Musculoskeletal & Ne
Page 241: KCE reports 57 Musculoskeletal & Ne
Page 249 and 250: KCE Reporst 57 Musculoskeletal & Ne
Page 275 and 276: KCE Reports 57 Musculoskeletal & Ne
Page 291: KCE Reports 57 Musculoskeletal & Ne
Page 294 and 295:
Dépôt légal : D/2007/10.273/19
Page 296:
35. Etude relative aux coûts poten
show all

The report is available in English with a French summary - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?